Theravance Biopharma, Inc.
2014 Q2 - 2025 Q4 (26 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/27/2026 | 16 | 0.0% | 868 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 13 | 0.0% | 868 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 14 | 0.0% | 1,246 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 12 | 0.0% | 1,382 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 160 | 0.0% | 16,978 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 137 | 0.0% | 16,978 | 9/30/2024 |
| 2024 Q2 | 7/29/2024 | 112 | 0.0% | 13,151 | 6/30/2024 |
| 2024 Q1 | 4/25/2024 | 118 | 0.0% | 13,158 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 105 | 0.0% | 9,330 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 61 | 0.0% | 7,103 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 78 | 0.0% | 7,560 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 86 | 0.0% | 7,952 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 88 | 0.0% | 7,868 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 84 | 0.0% | 8,280 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 75 | 0.0% | 8,280 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 82 | 0.0% | 8,548 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 63 | 0.0% | 5,718 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 42 | 0.0% | 5,718 | 9/30/2021 |
| 2021 Q2 | 7/30/2021 | 83 | 0.0% | 5,718 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 117 | 0.0% | 5,718 | 3/31/2021 |
| 2020 Q4 | 1/28/2021 | 102 | 0.0% | 5,718 | 12/31/2020 |
| 2020 Q3 | 11/6/2020 | 85 | 0.0% | 5,718 | 9/30/2020 |
| 2020 Q2 | 7/28/2020 | 73 | 0.0% | 3,495 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 81 | 0.0% | 3,495 | 3/31/2020 |
| 2019 Q4 | 1/21/2020 | 69 | 0.0% | 2,679 | 12/31/2019 |
| 2014 Q2 | 8/6/2014 | 364 | 0.0% | 11,428 | 6/30/2014 |